GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF

The invention relates to glycogen phosphorylase inhibitor compounds, pharmaceutical compositions of these compounds, methods of treatment using the pharmaceutical compositions to treat diabetes, conditions associated with diabetes, and/or tissue ischemia, including myocardial ischemia, and processes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	STEPHEN ANDREW THOMSON, PIERETTE BANKER, FRANCIS X. TAVARES, DULCE MARI GARRIDO, MEHUL P. PATEL, SCOTT HOWARD DICKERSON, JOEL P. COOPER, KAREN EVANS, KATE ANN DWORNIK, STEVEN MEAGHER SPARKS, YUE HU LI, ANDREW JAMES PEAT, JENNIFER PAUL GALE, FRANK TEEN COPPO, MARI CICHY-KNIGHT
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to glycogen phosphorylase inhibitor compounds, pharmaceutical compositions of these compounds, methods of treatment using the pharmaceutical compositions to treat diabetes, conditions associated with diabetes, and/or tissue ischemia, including myocardial ischemia, and processes for making the compounds. La invencion se refiere a compuestos del inhibidor glicogeno fosforilasa, composiciones farmaceuticas de estos compuestos, metodos de tratamiento que usan las composiciones farmaceuticas para tratar la diabetes, condiciones asociadas con la diabetes, y/o isquemia del tejido, incluyendo isquemia del miocardio, y procesos para elaborar los compuestos.